These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 16570188)

  • 1. Pharmacokinetics of piperaquine after repeated oral administration of the antimalarial combination CV8 in 12 healthy male subjects.
    Röshammar D; Hai TN; Friberg Hietala S; Van Huong N; Ashton M
    Eur J Clin Pharmacol; 2006 May; 62(5):335-41. PubMed ID: 16570188
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CV8, a new combination of dihydroartemisinin, piperaquine, trimethoprim and primaquine, compared with atovaquone-proguanil against falciparum malaria in Vietnam.
    Giao PT; de Vries PJ; Hung le Q; Binh TQ; Nam NV; Kager PA
    Trop Med Int Health; 2004 Feb; 9(2):209-16. PubMed ID: 15040557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Population pharmacokinetics of dihydroartemisinin and piperaquine in pregnant and nonpregnant women with uncomplicated malaria.
    Tarning J; Rijken MJ; McGready R; Phyo AP; Hanpithakpong W; Day NP; White NJ; Nosten F; Lindegardh N
    Antimicrob Agents Chemother; 2012 Apr; 56(4):1997-2007. PubMed ID: 22252822
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Population pharmacokinetics and electrocardiographic effects of dihydroartemisinin-piperaquine in healthy volunteers.
    Chotsiri P; Wattanakul T; Hoglund RM; Hanboonkunupakarn B; Pukrittayakamee S; Blessborn D; Jittamala P; White NJ; Day NPJ; Tarning J
    Br J Clin Pharmacol; 2017 Dec; 83(12):2752-2766. PubMed ID: 28695570
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The influence of food on the pharmacokinetics of piperaquine in healthy Vietnamese volunteers.
    Hai TN; Hietala SF; Van Huong N; Ashton M
    Acta Trop; 2008 Aug; 107(2):145-9. PubMed ID: 18585670
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Open-label crossover study of primaquine and dihydroartemisinin-piperaquine pharmacokinetics in healthy adult thai subjects.
    Hanboonkunupakarn B; Ashley EA; Jittamala P; Tarning J; Pukrittayakamee S; Hanpithakpong W; Chotsiri P; Wattanakul T; Panapipat S; Lee SJ; Day NP; White NJ
    Antimicrob Agents Chemother; 2014 Dec; 58(12):7340-6. PubMed ID: 25267661
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety, Pharmacokinetics, and Mosquito-Lethal Effects of Ivermectin in Combination With Dihydroartemisinin-Piperaquine and Primaquine in Healthy Adult Thai Subjects.
    Kobylinski KC; Jittamala P; Hanboonkunupakarn B; Pukrittayakamee S; Pantuwatana K; Phasomkusolsil S; Davidson SA; Winterberg M; Hoglund RM; Mukaka M; van der Pluijm RW; Dondorp A; Day NPJ; White NJ; Tarning J
    Clin Pharmacol Ther; 2020 May; 107(5):1221-1230. PubMed ID: 31697848
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of dihydroartemisinin and piperaquine in pregnant and nonpregnant women with uncomplicated falciparum malaria.
    Rijken MJ; McGready R; Phyo AP; Lindegardh N; Tarning J; Laochan N; Than HH; Mu O; Win AK; Singhasivanon P; White N; Nosten F
    Antimicrob Agents Chemother; 2011 Dec; 55(12):5500-6. PubMed ID: 21947392
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mass campaigns with antimalarial drugs: a modelling comparison of artemether-lumefantrine and DHA-piperaquine with and without primaquine as tools for malaria control and elimination.
    Gerardin J; Eckhoff P; Wenger EA
    BMC Infect Dis; 2015 Mar; 15():144. PubMed ID: 25887935
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A population pharmacokinetic model of piperaquine in pregnant and non-pregnant women with uncomplicated Plasmodium falciparum malaria in Sudan.
    Hoglund RM; Adam I; Hanpithakpong W; Ashton M; Lindegardh N; Day NP; White NJ; Nosten F; Tarning J
    Malar J; 2012 Nov; 11():398. PubMed ID: 23190801
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of piperaquine after single and multiple oral administrations in healthy volunteers.
    Liu C; Zhang R; Hong X; Huang T; Mi S; Wang N
    Yakugaku Zasshi; 2007 Oct; 127(10):1709-14. PubMed ID: 17917428
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of UGTs polymorphism on the auto-induction phase II metabolism-mediated pharmacokinetics of dihydroartemisinin in healthy Chinese subjects after oral administration of a fixed combination of dihydroartemisinin-piperaquine.
    Zang M; Zhu F; Zhao L; Yang A; Li X; Liu H; Xing J
    Malar J; 2014 Dec; 13():478. PubMed ID: 25476790
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Population pharmacokinetics of piperaquine after two different treatment regimens with dihydroartemisinin-piperaquine in patients with Plasmodium falciparum malaria in Thailand.
    Tarning J; Ashley EA; Lindegardh N; Stepniewska K; Phaiphun L; Day NP; McGready R; Ashton M; Nosten F; White NJ
    Antimicrob Agents Chemother; 2008 Mar; 52(3):1052-61. PubMed ID: 18180343
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety, tolerability, and single- and multiple-dose pharmacokinetics of piperaquine phosphate in healthy subjects.
    Ahmed T; Sharma P; Gautam A; Varshney B; Kothari M; Ganguly S; Moehrle JJ; Paliwal J; Saha N; Batra V
    J Clin Pharmacol; 2008 Feb; 48(2):166-75. PubMed ID: 18199893
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of food on the pharmacokinetics of piperaquine and dihydroartemisinin.
    Reuter SE; Evans AM; Shakib S; Lungershausen Y; Francis B; Valentini G; Bacchieri A; Ubben D; Pace S
    Clin Drug Investig; 2015 Sep; 35(9):559-67. PubMed ID: 26293519
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combining antimalarial drugs and vaccine for malaria elimination campaigns: a randomized safety and immunogenicity trial of RTS,S/AS01 administered with dihydroartemisinin, piperaquine, and primaquine in healthy Thai adult volunteers.
    von Seidlein L; Hanboonkunupakarn B; Jittamala P; Pongsuwan P; Chotivanich K; Tarning J; Hoglund RM; Winterberg M; Mukaka M; Peerawaranun P; Sirithiranont P; Doran Z; Ockenhouse CF; Ivinson K; Lee C; Birkett AJ; Kaslow DC; Singhasivanon P; Day NPJ; Dondorp AM; White NJ; Pukrittayakamee S
    Hum Vaccin Immunother; 2020; 16(1):33-41. PubMed ID: 31306084
    [No Abstract]   [Full Text] [Related]  

  • 17. Enantiospecific pharmacokinetics and drug-drug interactions of primaquine and blood-stage antimalarial drugs.
    Chairat K; Jittamala P; Hanboonkunupakarn B; Pukrittayakamee S; Hanpithakpong W; Blessborn D; White NJ; Day NPJ; Tarning J
    J Antimicrob Chemother; 2018 Nov; 73(11):3102-3113. PubMed ID: 30085149
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics and metabolism of the antimalarial piperaquine after intravenous and oral single doses to the rat.
    Tarning J; Lindegardh N; Sandberg S; Day NJ; White NJ; Ashton M
    J Pharm Sci; 2008 Aug; 97(8):3400-10. PubMed ID: 17969131
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetic Interactions between Tafenoquine and Dihydroartemisinin-Piperaquine or Artemether-Lumefantrine in Healthy Adult Subjects.
    Green JA; Mohamed K; Goyal N; Bouhired S; Hussaini A; Jones SW; Koh GC; Kostov I; Taylor M; Wolstenholm A; Duparc S
    Antimicrob Agents Chemother; 2016 Dec; 60(12):7321-7332. PubMed ID: 27697758
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Population pharmacokinetics of artesunate and dihydroartemisinin following intra-rectal dosing of artesunate in malaria patients.
    Simpson JA; Agbenyega T; Barnes KI; Di Perri G; Folb P; Gomes M; Krishna S; Krudsood S; Looareesuwan S; Mansor S; McIlleron H; Miller R; Molyneux M; Mwenechanya J; Navaratnam V; Nosten F; Olliaro P; Pang L; Ribeiro I; Tembo M; van Vugt M; Ward S; Weerasuriya K; Win K; White NJ
    PLoS Med; 2006 Nov; 3(11):e444. PubMed ID: 17132053
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.